Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency
ConclusionIron-based phosphate binder did not decrease serum FGF23 levels, but decreased serum PTH levels.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Chronic Kidney Disease | Dialysis | Hormones | Iron | Sodium | Study | Urology & Nephrology